Suppr超能文献

《协作性眼结核研究(COTS)-1 报告 3:聚合酶链反应在结核性葡萄膜炎的诊断和管理中的应用:全球趋势》。

The Collaborative Ocular Tuberculosis Study (COTS)-1 Report 3: Polymerase Chain Reaction in the Diagnosis and Management of Tubercular Uveitis: Global Trends.

机构信息

a Advanced Eye Centre , Postgraduate Institute of Medical Education and Research (PGIMER) , Chandigarh, India.

b National Healthcare Group Eye Institute , Tan Tock Seng Hospital , Singapore, Singapore.

出版信息

Ocul Immunol Inflamm. 2019;27(3):465-473. doi: 10.1080/09273948.2017.1406529. Epub 2017 Dec 20.

Abstract

: To analyze the role of polymerase chain reaction (PCR) of ocular fluids in management of tubercular (TB) anterior, intermediate, posterior, and panuveitis. In Collaborative Ocular Tuberculosis Study (COTS)-1 (25 centers,  = 962), patients with TB-related uveitis were included. 59 patients undergoing PCR of intraocular fluids (18 females; 53 Asian Indians) were included. 59 (6.13%) of COTS-1 underwent PCR analysis. PCR was positive for Mycobacterium TB in 33 patients (23 males; all Asian Indians). 26 patients were PCR negative (18 males). Eight patients with negative PCR had systemic TB. Anti-TB therapy was given in 18 negative and 31 PCR cases. At 1-year follow-up, five patients with positive PCR (15.15%) and three with negative PCR (11.54%) had persistence/worsening of inflammation. : Data from COTS-1 suggest that PCR is not commonly done for diagnosing intraocular TB and positive/negative results may not influence management or treatment outcomes in the real world scenario.

摘要

: 分析眼液聚合酶链反应(PCR)在结核性(TB)前、中、后和全葡萄膜炎治疗中的作用。在协作性眼结核研究(COTS)-1(25 个中心,=962)中,纳入了与 TB 相关的葡萄膜炎患者。纳入了 59 名接受眼内液 PCR 检查的患者(18 名女性;53 名亚裔印度人)。COTS-1 中有 59 人(6.13%)进行了 PCR 分析。33 名患者的 PCR 对结核分枝杆菌呈阳性(23 名男性;均为亚裔印度人)。26 名患者的 PCR 为阴性(18 名男性)。8 名 PCR 阴性的患者有全身 TB。18 名阴性和 31 名 PCR 患者接受了抗结核治疗。在 1 年的随访中,5 名 PCR 阳性患者(15.15%)和 3 名 PCR 阴性患者(11.54%)的炎症持续或恶化。COTS-1 的数据表明,PCR 通常不用于诊断眼内 TB,阳性/阴性结果可能不会影响真实世界环境中的管理或治疗结果。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验